Skip to main content
Amit Pandya, MD, Dermatology, Sunnyvale, CA

AmitGPandyaMD

Dermatology Sunnyvale, CA

Professor, Dermatology, University of Texas Southwestern Medical Center, Southwestern Medical School

Dr. Pandya is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Pandya's full profile

Already have an account?

Education & Training

  • University of Texas Southwestern Medical Center
    University of Texas Southwestern Medical CenterResidency, Dermatology, 1988 - 1991
  • Texas Health Resources (Dallas)
    Texas Health Resources (Dallas)Residency, Internal Medicine, 1985 - 1988
  • University of Texas Southwestern Medical School
    University of Texas Southwestern Medical SchoolClass of 1985

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2019 - 2025
  • TX State Medical License
    TX State Medical License 1986 - 2023
  • American Board of Dermatology Dermatology
  • American Board of Internal Medicine Internal Medicine

Awards, Honors, & Recognition

  • Regional Top Doctor Castle Connolly, 2014
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2012
  • Fellow (FAAD) American Academy of Dermatology
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • International Initiative for Outcomes (INFO) for Vitiligo: Workshops with Vitiligo Patients on Repigmentation  
    A Pandya, J E Harris, N Elbuluk, The British Journal of Dermatology

Lectures

  • Skin of Color 
    American Academy of Dermatology - Annual Meeting 2019 - Washington, D.C. - 3/1/2019
  • Closing the Gender Gap in Academic Dermatology and Dermatology Leadership: Problems and Solutions 
    American Academy of Dermatology - Annual Meeting 2019 - Washington, D.C. - 3/4/2019

Press Mentions

  • Incyte Announces Positive 52-Week Results from a Randomized Phase 2 Study of Ruxolitinib Cream in Patients with Vitiligo
    Incyte Announces Positive 52-Week Results from a Randomized Phase 2 Study of Ruxolitinib Cream in Patients with VitiligoOctober 12th, 2019
  • Why Aren't There More Black Dermatologists?
    Why Aren't There More Black Dermatologists?August 15th, 2019
  • What It’s like to Specialize in Dermatology: Shadowing Dr. Pandya
    What It’s like to Specialize in Dermatology: Shadowing Dr. PandyaJanuary 2nd, 2018

Professional Memberships